» Articles » PMID: 39091362

Lipodystrophy Following Covid-19 Vaccination: A Case Report

Overview
Journal Vaccine X
Date 2024 Aug 2
PMID 39091362
Authors
Affiliations
Soon will be listed here.
Abstract

Lipodystrophy is a medical condition characterized by complete or partial loss of adipose tissue. The etiology of lipoatrophy can be congenital or acquired, including traumatic, iatrogenic, or idiopathic. Rarely, vaccination can cause lipodystrophy. Here, we report the first case of lipodystrophy associated with the COVID-19 Sinopharm vaccine in a 55-year-old woman.

References
1.
Patone M, Handunnetthi L, Saatci D, Pan J, Katikireddi S, Razvi S . Neurological complications after first dose of COVID-19 vaccines and SARS-CoV-2 infection. Nat Med. 2021; 27(12):2144-2153. PMC: 8629105. DOI: 10.1038/s41591-021-01556-7. View

2.
Radermecker R, Pierard G, Scheen A . Lipodystrophy reactions to insulin: effects of continuous insulin infusion and new insulin analogs. Am J Clin Dermatol. 2007; 8(1):21-8. DOI: 10.2165/00128071-200708010-00003. View

3.
Lach B, Cupler E . Macrophagic myofasciitis in children is a localized reaction to vaccination. J Child Neurol. 2008; 23(6):614-9. DOI: 10.1177/0883073807312370. View

4.
Ramirez-Rivera J, Vega-Cruz A, Jaume-Anselmi F . Polymyositis: rare complication of hepatitis B vaccination. An unusual cause of toxic shock syndrome. Bol Asoc Med P R. 2004; 95(6):13-6. View

5.
Buntain W, Missall S . Letter: Local subcutaneous atrophy following measles, mumps, and rubella vaccination. Am J Dis Child. 1976; 130(3):335. DOI: 10.1001/archpedi.1976.02120040113022. View